Pharma Pulse 11/27/24: Practical Gains for Pharma AI Use, Key Trends in the Evolution of PBMs & more

The Leap Forward: Practical Gains for Pharma AI Use

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Once relatively obscure, PBMs are now front and center in debates over drug pricing and access. Their future role will have profound implications not only for how medications are priced but also for how pharmacies conduct their operations.

Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion

Poseida is a public clinical-stage biopharmaceutical company which creates donor-derived CAR-T cell therapies.

Care Access Launches Health Screening Initiative in Birmingham to Address Undetected Heart & Kidney Health Risks

Care Access is making its Heart & Kidney Health Screening initiative available to residents of Birmingham, Ala. This health screening raises awareness and provides testing for certain health risk factors, including a dangerous type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five people and significantly increases the risk of heart disease and stroke.

Timothy Marsh on LinkedIn

Neat, looking forward to the coming episodes!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs